Description
Benefits
- Supports sexual desire and arousal through central brain pathways (PT-141)
- Enhances emotional connection, bonding, and intimacy (Oxytocin)
- Supports blood flow and physical performance (Tadalafil)
- Addresses both psychological and physiological contributors to intimacy
- Suitable for both men and women depending on clinical goals
- Convenient, discreet troche delivery format
Background and History
- PT-141 (bremelanotide) was developed to target melanocortin receptors involved in sexual desire
- Oxytocin is a naturally occurring neuropeptide central to bonding, trust, and emotional regulation
- Tadalafil is a PDE-5 inhibitor widely used to support blood flow and sexual performance
- Central-acting and peripheral-acting therapies were combined to address desire and mechanics together
- Troche formulations emerged to improve ease of use and mucosal absorption
- Combination protocols became popular in sexual-wellness and performance optimization settings
